Russia's Oncology Drugs Market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022-30 and will reach $xx Bn in 2030. The rising oncology burden in Russia owing to the increased consumption of alcohol and tobacco is driving the growth of the global oncology market. The market is segmented by Drug Class, Therapy, Indication, Dosage Form, and Distribution Channel. The major companies in Russia's Oncology Drugs Market are Roche, Bristol-Myers Squibb, Veropharm (Abbott), MSD, Sanofi, Novartis, and others.
Russia's Oncology Drugs Market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022-30 and will reach $xx Bn in 2030. Over the past few years, Russia has spent an average of 5% of its GDP on healthcare, which is less than OECD nations, which spend close to 10% of their GDP on healthcare (Macrotrends, 2021). Russia’s Annual Household Income per Capita reached $6.52 Bn in Dec 2021, compared with the previous value of $6.031 In Dec 2020. Russia’s Annual Household Income per Capita data is updated yearly, available from Dec 1992 to Dec 2021, with an average value of $5 Bn.
In Russia, the accumulated risk of developing cancer by the age of 75 was 24.7% (29.4% were men and 22.3% – were women). By the end of 2014, registered cancer care facilities were 3.29 Mn patients which is responsible for this phenomenon and consequently leading to the growth of the market. There are annually about 2 Mn cancer patients in need of palliative care that is inaccessible (for drug-related regulatory reasons) for a great number of patients. In terms of five-year the survival rate, in 2014 only 52.4% of cancer patients could overcome the five-year period after first being diagnosed. Therefore, the increasing need for cancer treatment is expected to boost the demand for the global oncology cancer drugs market during the forecast period.
Market Growth Drivers
The growth of the oncology drug market is attributed to the population of Russia ages, and the incidence of cancer is expected to increase. The surge in the incidence of cancer across the country, the increase in the aging population (16% of Russia’s total population is above 65 age), and, the surge in the number of pipeline drugs and untapped potential in emerging geographies create new opportunities in the market. Due to the availability of new and innovative treatments, the oncology drug market is expected to benefit from the introduction of new and innovative treatments, including targeted therapies and immunotherapies. Moreover, the adoption of personalized medicine approaches personalized medicine, which involves tailoring treatment to the individual characteristics of each patient, is expected to play a significant role in the growth of the oncology drug market in Russia.
Market Restraints
Adverse effects related to the usage of cancer drugs hinder market growth. negatively influencing the growth of the market. and biological data to identify potential drug candidates with higher success rates than human analysis.
Key Players
Key players in the oncology market include
September 2021: Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, announces that it has signed a license agreement with the Swiss-based FarmaMondo Group for the commercialization of Paclical® (Apealea®) in Russia and the Commonwealth of Independent States.
Policy changes and Reimbursement scenario of Russia Oncology Drugs Services
In 2011, 5 targeted cancer therapies were covered in the essential drug list (Bevacizumab, Rituximab, Trastuzumab, Imatinib and Bortezomib). In 2012, an additional 8 branded cancer drugs were added to the list, expanding the coverage of targeted cancer therapies to 13 products. The price change trend for selected analogs shows some products covered at the same price, while for others price was reduced by 5-10%. For example, one of the covered monoclonal antibodies’ prices did not change during 2011 and 2012, while prices for a proteasome inhibitor and a tyrosine kinase inhibitor were lowered by 6% and 10%, respectively.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Drug class
By Therapy
By Indication
By Dosage form
By Distribution channel
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?